A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain

NCT02081690 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
160
Enrollment
INDUSTRY
Sponsor class

Stopped Slow recruitment

Conditions

Interventions

Sponsor

Actelion